Autoimmune Diseases  >>  NNC 0151-0000-0000  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NNC 0151-0000-0000 / Novo Nordisk
NCT02151409: Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects

Completed
1
60
Europe
NNC 0151-0000-0000, placebo
Novo Nordisk A/S
Inflammation, Systemic Lupus Erythematosus, Rheumatoid Arthritis, Healthy
10/09
10/09
NCT01018238: An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

Withdrawn
1
0
US
NNC 0151-0000-0000, placebo
Novo Nordisk A/S
Inflammation, Systemic Lupus Erythematosus
11/09
11/09

Download Options